Scribd
Upload
61 views2 pages

M.I. (Losartan) Drug Study)

This nursing care plan is for a 49-year-old male patient diagnosed with hypertension stage II and kidney stones who is prescribed Losartan (Kenazr) 50mg daily by mouth. The nurse's responsibilities include monitoring the patient's blood pressure before and after medication administration, assessing for side effects such as hypotension and checking lab results for electrolyte and renal function. The patient should be instructed on blood pressure monitoring and reporting symptoms of hypotension or pregnancy.

Uploaded by

Angelica Marie Macasling
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
61 views2 pages

M.I. (Losartan) Drug Study)

This nursing care plan is for a 49-year-old male patient diagnosed with hypertension stage II and kidney stones who is prescribed Losartan (Kenazr) 50mg daily by mouth. The nurse's responsibilities include monitoring the patient's blood pressure before and after medication administration, assessing for side effects such as hypotension and checking lab results for electrolyte and renal function. The patient should be instructed on blood pressure monitoring and reporting symptoms of hypotension or pregnancy.

Uploaded by

Angelica Marie Macasling
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 2

COLLEGE OF ALLIED MEDICAL PROFESSIONS

BACHELOR OF SCIENCE IN NURSING


NURSING CARE PLAN

Patient’s Initial: _______M.I.______________ Age: ___49__________ Date of Birth: ______12/19/1973_____ Gender: _____MALE__________
Chief Complaint: ________Hypogastric Pain _______ Medical Diagnosis: _______T/C Nephrolithiasis, HTN stage II______________ Room/Bed #: ____328-B______

DATE CLIENT’S NURSING


ROUTE OF RESPONSE
ORDERED/ RESPONSIBILITIES
ADMINISTRATION MECHANISM CONTRAINDICA (THERAPEUTIC
MEDICATION GIVEN OR INDICATION (PRIOR, DURING,
/ DOSAGE/ OF ACTION TION EFFECT, SIDE
TAKEN/ AFTER – AT LEAST 3
FREQUENCY EFFECT, ADVERSE
EACH)
DISCONTINUED EFFECT)
Generic: Date Ordered: Route: P.O Losartan Management of Hypersensitivity. Therapeutic Effect: Prior:
September 10, 2023 potassium HTN particularly Renal artery stenosis Reduced levels of  Monitor BP at
Losartan (KENZAR) is in patients who & hyperkalemia. active metabolite w/ drug trough
readily absorbed develop cough w/ Concomitant use w/ rifampin & (prior to a
from the ACE inhibitors & K-sparing diuretics. fluconazole. scheduled dose).
Date Given: Dosage: 50mg gastrointestinal to reduce the risk Pregnancy & lactation. Increased serum K w/  Inadequate
Brand: September 10, 2023 tract following of stroke in K-sparing diuretics K response may be
oral patients w/ left supplements or salt improved by
Kenzar
administration. It ventricular containing K. splitting the
undergoes first hypertrophy & in Attenuated daily dose into
pass metabolism the treatment of antihypertensive twice-daily dose.
Date Discontinued: Frequency: to form an active diabetic effect w/ NSAID  Lab tests:
carboxylic acid nephropathy. 50 indomethacin. Monitor CBC,
Classification: metabolite which mg tab: electrolytes, liver
Angiotensin II
has a greater Management of & kidney
Antagonists
pharmacological heart failure. function with
activity. Peak long-term
plasma Side Effect: therapy
concentration is During:

Submitted by: ____________________________________ Section/Group #: _________ Submitted to: _____________________ Hospital/Area: ______________ Date: ___________
achieved in about • may cause hypotension,
1 hour after an tacycardia, angiodema,
oral dose. It is hyperkalemia
98% bound to • may increase digoxin
plasma protein. It levels
is excreted in Adverse Effect: • assess blood pressure
urine and in feces Adverse effects have and heart rate
as unchanged drug been reported to be • assess fluid levels
and metabolites. usually mild and • monitor daily weights
Following oral transient in nature. with CHF
dose, about 4% of The most common • monitor renal and liver
the dose is drug-related side • instruct patient on how
excreted effects were to take blood pressure
unchanged in dizziness, After:
urine and about asthenia/fatigue, and Notify physician of
6% in urine as the vertigo. The overall symptoms of
active metabolite. incidence of side hypotension (e.g.,
effects reported with dizziness, fainting).
Losartan potassium Notify physician
was comparable to immediately of
placebo. pregnancy.
View Do not breast feed while
taking this drug

Submitted by: ____________________________________ Section/Group #: _________ Submitted to: _____________________ Hospital/Area: ______________ Date: ___________

You might also like